Literature DB >> 26227072

Survival in Subcortical Vascular Dementia: Predictors and Comparison to Probable Alzheimer's Disease in a Tertiary Memory Clinic Population.

Jong Hun Kim1, Seok Min Go, Sang Won Seo, Suk Hui Kim, Juhee Chin, So Young Moon, Hyunsun Lim, Hae Kwan Cheong, Sun Ah Choi, Jun Hong Lee, Duk L Na.   

Abstract

BACKGROUND: Subcortical vascular dementia (SVaD) is one of the most common dementias, after Alzheimer's disease (AD) dementia. Few survival analyses in SVaD patients have been reported.
METHODS: The dates and causes of death of 146 SVaD and 725 AD patients were included. We used the Cox proportional hazards model to compare survival between SVaD and AD patients and to explore possible factors related to survival of SVaD patients.
RESULTS: The median survival time after the onset of SVaD (109 months) was shorter than that recorded for AD (152 months). The most common cause of death in SVaD was stroke (47.1%). Factors associated with shorter survival in SVaD were late onset, male sex, worse baseline cognition, absence of hypertension and a family history of stroke.
CONCLUSIONS: Stroke prevention may be important in SVaD treatment because 47.1% of SVaD patients died of stroke. A family history of stroke and absence of hypertension were associated with a shorter survival in SVaD, suggesting the existence of genetic or unknown risk factors.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26227072     DOI: 10.1159/000434626

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  2 in total

1.  Predictors of Mortality in Individuals with Dementia in the National Alzheimer's Coordinating Center.

Authors:  Melissa J Armstrong; Shangchen Song; Andrea M Kurasz; Zhigang Li
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

2.  Bilingual problem-solving training for caregivers of adults with dementia: A randomized, factorial-design protocol for the CaDeS trial.

Authors:  ShannonB Juengst; Charlene Supnet; Chung Lin Novelle Kew; Valeria Silva; Marlene Vega; Gang Han; Brendan Kelley; Matthew Lee Smith; Gladys Maestre
Journal:  Contemp Clin Trials       Date:  2021-07-15       Impact factor: 2.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.